Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare Biotechnology

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd

Bullboard Posts

Post by blackgold909on Sep 27, 2018 7:34am

232 Views

Post# 28698977

Another Insider sale of a 1mln shares

Insider Filings

Latest 10 SEDI filings for HUGE within the last 6 months

Amended Filing

As of 11:59pm ET September 26th, 2018

Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	Volume or Value	Price
Sep 26/18	Sep 21/18	Klacar, Vladimir	Direct Ownership	Subordinate Voting Shares Class B	10 - Disposition in the public market	-1,000,000	$0.870
Sep 26/18	Sep 21/18	Klacar, Vladimir	Direct Ownership	Subordinate Voting Shares Class B	51 - Exercise of options	1,000,000	$0.090